Related changes
← GPR149
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
11 July 2025
- Report bugs. | #UCB_Gadget)
10 July 2025
- Report bugs. | #UCB_Gadget)
- diffhist Free fatty acid receptor 3 07:50 +16 Headbomb talk contribs (→Ligands: |doi-access=free)
- diffhist Free fatty acid receptor 3 07:44 +13 Meodipt talk contribs (→Ligands)
- diffhist Free fatty acid receptor 3 07:44 +253 Meodipt talk contribs (→Ligands)
9 July 2025
- diffhist Free fatty acid receptor 3 19:45 +328 Meodipt talk contribs (CF3-MQC and AR399519 might be the same compound, they are from the same patent which only discloses 4 structures for FFAR3 antagonists, but since the structure of AR399519 has not been disclosed we can't be sure)
- diffhist Free fatty acid receptor 3 19:11 −48 Meodipt talk contribs (where they say "A FFAR2- and FFAR3–specific agonist...... (CFMB)/AR420626" they mean CFMB is the FFAR2 agonist and AR420626 is the FFAR3 agonist, not that they are the same compound acting at FFAR2/3. Poor wording in the source paper.)
- diffhist Free fatty acid receptor 3 19:08 +22 Meodipt talk contribs (→Activating and inhibiting agents)
8 July 2025
- diffhist Free fatty acid receptor 2 21:38 +23 Meodipt talk contribs (→Ligands)
- diffhist Free fatty acid receptor 3 21:38 −1 Meodipt talk contribs (→Activating and inhibiting agents)
- diffhist Free fatty acid receptor 3 21:37 −107 Meodipt talk contribs (actually CFMB appears to be FFAR2 selective with only weak action at FFAR3)
- diffhist Free fatty acid receptor 3 19:09 +12 Meodipt talk contribs (→Ligands)
- diffhist Free fatty acid receptor 3 19:09 +11 Meodipt talk contribs (→Ligands)
- diffhist Free fatty acid receptor 3 19:08 +1 Meodipt talk contribs (→Activating and inhibiting agents)
- diffhist Free fatty acid receptor 3 19:08 −25 Meodipt talk contribs (AR420626 and CFMB are different compounds with quite distinct structures, seems to be a bit of confusion about which ligand is which for these FFAR receptors)
7 July 2025
- diffhist P2RY10 18:56 +1 Howard Cheni talk contribs Tag: Visual edit
- Undo
- diffhist Rhodopsin 17:17 −248 66.9.166.61 talk Tag: Reverted
- Report bugs. | #UCB_Gadget)
- diffhist Alpha-2 adrenergic receptor 07:05 −10 173.3.74.88 talk
- diffhist Alpha-1 adrenergic receptor 07:04 −18 173.3.74.88 talk
- diffhist Alpha-1 adrenergic receptor 07:04 −18 173.3.74.88 talk
- Undo
- diffhist Relaxin/insulin-like family peptide receptor 1 05:16 +1 197.211.63.137 talk (Punctuation) Tags: Reverted Visual edit
6 July 2025
- diffhist TAS1R2 16:18 0 JK96186 talk contribs (structural details) Tag: Visual edit
- diffhist TAS1R2 16:07 +1,256 JK96186 talk contribs Tag: Visual edit
- diffhist Μ-opioid receptor 16:02 −5 Headbomb talk contribs (ce)
- diffhist Bradykinin receptor B2 13:54 −172 Toadspike talk contribs (Remove subscript from "2" in B2. A PubMed search shows that sources overwhelmingly write "B2R" or variations without a subscript.) Tag: 2017 wikitext editor
- diffhist Beta-2 adrenergic receptor 13:53 +72 Toadspike talk contribs (Hatnote to Bradykinin receptor) Tag: 2017 wikitext editor
- diffhist Beta-1 adrenergic receptor 13:51 +72 Toadspike talk contribs (Add hatnote (nailed it in source editor in one shot, so happy)) Tag: 2017 wikitext editor
5 July 2025
- diffhist Adenosine receptor 19:40 −16 24.148.36.209 talk (→In the brain: updated citation)
- diffhist Adenosine receptor 10:31 +3 144.82.114.247 talk (→In the brain) Tag: Visual edit
- diffhist Adenosine receptor 10:29 +1,106 144.82.114.247 talk (→A2B adenosine receptor) Tag: Visual edit
4 July 2025
- Undo
- diffhist PubMed 22:24 +4 110.54.216.189 talk (Give an example that is truly made by the Reasearch studies and find a research studies and how they present the statement in real research papers each parts on (Background of the Study, Statement of the Problem, Scope and Delimitation, Significance of the Study, The Importance of Related Theories and Concepts, and The Purposes of Related Studies and Related Studies)) Tags: Reverted Mobile edit Mobile web edit
- diffhist Wikidata 17:18 +65 125.26.30.147 talk (→Conceptmrmaitreemeechana.0849743700ture.ok)) Tags: Reverted Mobile edit Mobile web edit
- diffhist m TAS1R2 16:12 +163 JK96186 talk contribs (→Structure and molecular function) Tag: Visual edit